RxSight, Inc. expects revenue of $37.9 million in Q1 2025, revises full-year guidance lower.

From GlobeNewswire: 2025-04-02 20:00:00

RxSight, Inc. announced preliminary revenue results for the first quarter of 2025, with expected revenue of approximately $37.9 million, driven by increased procedure volume and expansion of Light Delivery Devices. The company also revised its full-year 2025 guidance, decreasing revenue expectations to $160.0 million to $175.0 million and operating expenses to $150.0 million to $160.0 million. RxSight will host a conference call on April 3, 2025, to discuss these results and provide further information. The unaudited financial results for the first quarter of 2025 will be announced on May 7, 2025, followed by another conference call.



Read more at GlobeNewswire: RxSight, Inc. Announces Preliminary First Quarter 2025